患者报告结局测量系统(PROMIS®)用于泌尿系结石患者:初步报告
本研究在肾脏结石专科门诊采集1,162例患者的2,018份完整PROMIS疼痛测量(强度与干扰)问卷,比较四种临床场景下的T评分。结果显示疼痛强度与干扰T评分随就诊类型显著不同(p<0.001),多因素分析中各就诊类型相对于术后随访的T评分>60的OR均更高。女性与较年轻年龄是T评分>60的独立危险因素。
要点
- PROMIS疼痛测量可反映有症状结石事件不同诊疗阶段的患者体验。
- 各就诊类型相对于术后随访,疼痛强度与干扰T评分>60的OR均更高(p<0.001)。
- 女性与较年轻年龄是T评分>60的独立危险因素。
核心结论
- PROMIS疼痛测量对有症状结石事件诊疗阶段具有反应性,进一步应用该工具作为改善泌尿系结石诊疗质量的工具具有很大潜力。
研究设计与样本
- 在肾脏结石专科门诊获取患者的PROMIS疼痛测量(强度与干扰),考虑急诊科随访、尝试排石、支架取出和术后1个月发现四类临床就诊类型,将原始评分转换为人群常模T评分(T评分50为参考人群均值,60为高于均值1个标准差),并进行单因素和多因素分析比较各就诊类型的T评分。
主要发现
- 共从1,162例患者获得2,018份完整问卷。
- 平均疼痛强度与疼痛干扰T评分按就诊类型差异显著(p<0.001)。
- 多因素分析中,相对于术后发现,所有就诊类型的疼痛强度与干扰T评分>60的OR均更高,包括急诊科随访37.9 vs 124.9、尝试排石5.4 vs 10.5和支架取出9.4 vs 30.2(p<0.001)。
- 女性与较年轻年龄是T评分>60的独立危险因素。
关键数值与推荐
- T评分50为参考人群均值,60为高于均值1个标准差。
- 疼痛强度与干扰T评分按就诊类型差异显著(p<0.001)。
- 相对于术后发现,疼痛强度与干扰T评分>60的OR:急诊科随访37.9 vs 124.9、尝试排石5.4 vs 10.5、支架取出9.4 vs 30.2(p<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Health related quality of life is increasingly important in quality improvement efforts for medical conditions. However, it has proved challenging to measure health related quality of life for urolithiasis, given the distinct chronic and acute phases of this disease. We evaluated the use of PROMIS® (Patient-Reported Outcomes Measurement System) to assess the patient experience through acute stone episode stages. MATERIALS AND METHODS: PROMIS pain measures (intensity and interference) were obtained from patients at a subspecialty kidney stone clinic. Four types of clinical encounters were considered, including emergency department followup, trial of passage, stent removal and 1-month postoperative findings. Raw scores were translated into population normed T-scores with a T-score of 50 considered the reference population mean and a score of 60 considered 1 SD above the mean. T-scores were compared across encounter types on univariate and multivariate analysis. RESULTS: A total of 2,018 complete surveys were available from 1,162 patients. Mean pain intensity and pain interference T-scores differed significantly by encounter type (p <0.001). On multivariate analysis the OR of T-scores greater than 60 was higher for pain intensity and interference for all encounter types relative to postoperative findings, including emergency department followup 37.9 vs 124.9, passage trial 5.4 vs 10.5 and stent removal 9.4 vs 30.2 (p <0.001). Additionally, female gender and younger age were independent risk factors for T-scores greater than 60. CONCLUSIONS: PROMIS pain measures are responsive to the phase of care during symptomatic stone events. Further application of this instrument holds great potential as a valuable tool to improve the quality of urolithiasis care.
引用
- Borofsky MS, Lane GI, Neises SM, et al. Patient-Reported Outcomes Measurement System (PROMIS®) for Patients with Urolithiasis: Initial Report. J Urol. 2017. PMID: 28587919. doi:10.1016/j.juro.2017.05.080
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。